facebook

17th Semi-Annual Diagnostic Coverage & Reimbursement Conference

December 8-9, 2020 | Boston, MA

17th Semi-Annual Diagnostic Coverage & Reimbursement Conference
December 8-9, 2020 | Boston, MA

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I would definitely return next year. The speakers were people in the industry who are challenging to get access to via phone and email. They were all willing to chat post-meeting and were easily accessible.”

National Director, Market Access
Adaptive Biotechnologies

“Best reimbursement conference I have been to, ever.”

Vice President, Commercial Operations
Trovagene

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

In the increasingly competitive diagnostic market, coverage and reimbursement professionals seek practical insight into successful strategies to develop test-specific frameworks and meet the growing need for clinical utility and product performance evidence. In particular, tactics to clearly define end-points in diagnostic clinical trial design, as well as methods to advantageously position real-world evidence to maximize the product value demonstration to payers are currently on the industry’s radar. Proactive solutions are needed as reimbursement leaders strive to maximize profitability within the context of decreasing payment rates due to PAMA as well as increasing requirements for prior authorization.

Core Topics to be Addressed:

  • Defining & demonstrating clinical utility for a variety of diagnostic tests
  • Identification of end-points based on test type to prove clinical value
  • Payer interest in real-world evidence & health economic information
  • Positioning health economic data within the larger value proposition
  • Optimizing timelines for obtaining PLA codes and coverage decisions

Program Highlights:

  • Targeted insight into recent policy developments
  • Engaging workshops & small group discussions
  • Focus on knowledge-share & participatory learning

Core Topics to be Addressed:

  • Defining & demonstrating clinical utility for a variety of diagnostic tests
  • Identification of end-points based on test type to prove clinical value
  • Payer interest in real-world evidence & health economic information
  • Positioning health economic data within the larger value proposition
  • Optimizing timelines for obtaining PLA codes and coverage decisions

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from laboratories and diagnostic companies

Distinguished Presenters

Speaker recruitment in progress

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This